Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 8 Gynecologic 1 CNS 1 Breast 1

Conditions

Uterine Cervical Neoplasms 3 Ovarian Neoplasms 3 Peritoneal Neoplasms 2 Endometrial Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Papillomavirus Infections 1 Neoplasms 1 Motor Activity 1 Lung Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Colonic Diseases 1 Cervical Cancer Screening 1 Breast Neoplasms 1

Interventions

Paclitaxel 28 Carboplatin 28 pembrolizumab 25 Bevacizumab 14 liposomal doxorubicin 12 Cisplatin 11 Gemcitabine 10 Radiotherapy 8 Drug Therapy 8 Cyclophosphamide 8 Blood Specimen Collection 8 Topotecan 7 Nivolumab 7 olaparib 6 Doxorubicin 6 niraparib 5 Therapeutics 5 Dexamethasone 5 pertuzumab 4 pazopanib 4 lenvatinib 4 fludarabine 4 cemiplimab 4 atezolizumab 4 Trastuzumab 4 Surveys and Questionnaires 4 Psychiatric Rehabilitation 4 Polymerase Chain Reaction 4 Fulvestrant 4 Docetaxel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Control Groups × Gynecologic × Clear all

NCT05149248 2021-12-08

CONDESA

Instituto Nacional de Salud Publica, Mexico

Phase 2/3 Completed

Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡